{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:04:57Z","timestamp":1787792697379,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/sla.0b013e3181c3c36d","type":"journal-article","created":{"date-parts":[[2010,2,19]],"date-time":"2010-02-19T03:20:11Z","timestamp":1266549611000},"page":"488-492","source":"Crossref","is-referenced-by-count":77,"title":["Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers"],"prefix":"10.1097","volume":"251","author":[{"given":"Reinoutje","family":"Kaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senno","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti A.","family":"Rookus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester S. A.","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jeanne Vrancken","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel J. T.","family":"Rutgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210203","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1 mutation carriers.","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"R2-17-20210203","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families.","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Human Genet"},{"key":"R3-17-20210203","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMcp071286","article-title":"Management of inherited predisposition of breast cancer.","volume":"357","author":"Robson","year":"2007","journal-title":"N Engl J Med"},{"key":"R4-17-20210203","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2407-8-155","article-title":"Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family.","volume":"8","author":"Evans","year":"2008","journal-title":"BMC Cancer"},{"key":"R5-17-20210203","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group.","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"key":"R6-17-20210203","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1245\/s10434-007-9449-x","article-title":"Prophylactic mastectomy in BRCA1\/2 mutation carriers and women at risk of hereditary breast cancer: long term experiences at the Rotterdam Family Cancer Clinic.","volume":"14","author":"Heemskerk-Gerritsen","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R7-17-20210203","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer estimates for BRCA1 mutation carriers identified in a risk evaluation program.","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R8-17-20210203","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers.","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R9-17-20210203","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2005.02.7888","article-title":"Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1\/2-associated stage I\/II breast cancer.","volume":"24","author":"Pierce","year":"2006","journal-title":"J Clin Oncol"},{"key":"R10-17-20210203","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","article-title":"Outcome of conservatively managed early-onset breast cancer by BRCA1\/2 status.","volume":"359","author":"Haffty","year":"2002","journal-title":"Lancet"},{"key":"R11-17-20210203","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjc.6602703","article-title":"Risk reduction of contralateral prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers.","volume":"93","author":"Sprundel TC van, S Schmidt","year":"2005","journal-title":"Br J Cancer"},{"key":"R12-17-20210203","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1200\/JCO.2005.10.080","article-title":"Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.","volume":"23","author":"Herrinton","year":"2005","journal-title":"J Clin Oncol"},{"key":"R13-17-20210203","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2001.19.19.3938","article-title":"Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.","volume":"19","author":"McDonnell","year":"2001","journal-title":"J Clin Oncol"},{"key":"R14-17-20210203","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer.","volume":"227","author":"Burke","year":"1997","journal-title":"JAMA"},{"key":"R15-17-20210203","first-page":"1","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: update and extensions.","author":"Antoniou","year":"2008","journal-title":"BJC"},{"key":"R16-17-20210203","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","article-title":"Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up.","volume":"90","author":"Olivier","year":"2004","journal-title":"Br J Cancer"},{"key":"R17-17-20210203","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","article-title":"Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.","volume":"93","author":"Hartmann","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R18-17-20210203","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/cncr.11225","article-title":"Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.","volume":"97","author":"Kauff","year":"2003","journal-title":"Cancer"},{"key":"R19-17-20210203","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.ejca.2006.05.027","article-title":"Numerous high-risk epithelial lesions in familial breast cancer.","volume":"42","author":"Hoogerbrugge","year":"2006","journal-title":"Eur J Cancer"},{"key":"R20-17-20210203","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9610(00)00458-X","article-title":"The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy.","volume":"180","author":"Dupont","year":"2000","journal-title":"Am J Surg"},{"key":"R21-17-20210203","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/cncr.23298","article-title":"Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?","volume":"112","author":"McLaughlin","year":"2008","journal-title":"Cancer"},{"key":"R22-17-20210203","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/cncr.22176","article-title":"Selective use of sentinel lymph node surgery during prophylactic mastectomy.","volume":"107","author":"Boughey","year":"2006","journal-title":"Cancer"},{"key":"R23-17-20210203","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1245\/s10434-007-9356-1","article-title":"Detect occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymp node biopsy.","volume":"14","author":"Black","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R24-17-20210203","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1245\/s10434-006-9264-9","article-title":"Is routine lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-womens hospital experience.","volume":"14","author":"Soran","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R25-17-20210203","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1054\/bjoc.2000.1239","article-title":"Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer.","volume":"83","author":"Verhoog","year":"2000","journal-title":"Br J Cancer"},{"key":"R26-17-20210203","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1158\/1078-0432.CCR-07-0146","article-title":"BRCA mutations in women with ductal carcinoma in situ.","volume":"13","author":"Smith","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R27-17-20210203","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejso.2007.04.015","article-title":"Stage of breast cancers found during the surveillance of women with a familial or hereditary risk.","volume":"34","author":"Kaas","year":"2008","journal-title":"Eur J Surg Oncol"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000658-201003000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:14:36Z","timestamp":1786040076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000658-201003000-00017"}},"subtitle":["Very Low Risk for Subsequent Breast Cancer"],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0b013e3181c3c36d","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}